ABSTRACT
INTRODUCTION
Alcohol abuse is well known to impair reproductive function (1) and alcoholics are found having fertility abnormalities with low sperm count and impaired sperm motility (2) . In our previous study (3) with chronic ethanol treated rats we reported reduction in body and testis weight, decrease in testicular ascorbic acid, reduced glutathione (GSH) and activities of superoxide dismutase (SOD), catalase, glutathione reductase (GR), glutathione peroxidase (GPx), 3 β-hydroxy steroid dehydrogenase (3 beta-HSD) and 17 β-hydroxy steroid dehydrogenase (17 beta-HSD).
L-ornithine-L-aspartate is stable salt of the amino acids ornithine and aspartic acid and is a nutritional supplement that has been investigated as a treatment for cirrhosis and hepatic encephalopathy (4) . Oral L-ornithine-L-aspartate is a safe, well-tolerated treatment with a good compliance rate and a beneficial therapeutic effect in patients with cirrhosis(4). The liver is exposed to the higher concentrations of alcohol in blood and is responsible for more than 95% of its metabolism (5) . 75% of the men with advanced alcoholic cirrhosis have been reported to have testicular atrophy (6) . In view of the possible role of liver in ethanol induced testicular injury the present study was designed to investigate the effect of Lornithine-L-aspartate on ethanol induced testicular injury in Wistar rats.
MATERIALS AND METHODS
Fine chemicals were purchased from Sisco Research Laboratory, India and Sigma Chemical Co., St. Louis, USA. All other chemicals used were of analytical grade and were purchased from Merck Ltd., India and Sisco Research Laboratories Ltd., India. L-ornithine-L-aspartate (150mg/tab) was procured from HepaMerz, Win-Medicare, India.
Male Wistar rats (10-12 weeks of age) weighing 100-120 g were used. The animals were housed in plastic cages of size 14"×9"×8" (6 rats in each cage) in side a well-ventilated room. The room temperature was maintained at 22 ± 2°C with a 12-12 hr L: D cycle. All rats had free access to a standard diet and water. National Institutes of Health (NIH), Bethesda, MD, USA guidelines were followed for maintenance, handling, experimentation, sacrifice and disposal of animals. The experimental study protocol was approved by the Institutional Animal Ethics Committee, SMIMS, Gangtok.
The dose of ethanol was determined as described previously (4) . The animals were divided in to 5 groups of 6 each i.e. Group I (Control): 1g double distilled water/kg b.wt/day for 4 weeks, orally; Group II: Ethanol treated rats (1.6g ethanol/kg b.wt/day for 4 weeks, orally); Group III: Ethanol + L-ornithine-L-aspartate treated rats (1.6g ethanol + 200mg L-ornithine-Laspartate/kg b.wt/day for 4 weeks, orally); Group IV: Ethanol followed by L-ornithine-L-aspartate treated rats (1.6g ethanol/ kg b.wt/day for 4 weeks followed by 200mg L-ornithine-Laspartate/kg b.wt/day for next 4 weeks, orally); Group V: Ethanol treatment (1.6g ethanol/kg b.wt/day, orally) for 4 weeks and followed by 4 weeks abstinence.
Rats were weighed and killed by cervical dislocation under light ether anesthesia; kidney were removed, cleaned of the adhering tissues and weighed. Tissues were immediately rinsed with ice cold normal saline, trimmed and processed for biochemical analysis.
Biochemical analysis-Total protein (7), extent of lipid peroxidation (8) , ascorbic acid (9), reduced glutathione (GSH) (10), catalase (EC 1.11.1.6) (11), superoxide dismutase (SOD, EC 1.15.1.1) (12), glutathione peroxidase (Se-GSH-Px, EC 1.11.1.9) (13), glutathione reductase (GSH-Red, EC 1.6.4.1) (14), glutathione-S-transferase (GSH-ST, EC 2.5.1.18) (15), D5, 3β-hydroxy steroid dehydrogenase (D5, 3β-HSD) (16) and 17β-hydroxy steroid dehydrogenase (17β-HSD) (17) were estimated.
The data were expressed as mean ± SD. Statistical analysis was performed using Student's't' test for unpaired data. Significance of difference was set at P<0.05.
RESULTS
L-ornithine-L-aspartate effectively prevented the ethanol induced body and testes weight reduction (Table 1) , however changes in testicular weight well correlated with body weight. Ethanol treated group demonstrated significantly high extent of lipid peroxidation in testes and decrease in testicular ascorbic acid and reduced glutathione ( Table 2 ). The activities of SOD, catalase, GSH-Red and Se-GSH-Px were found to be significantly decreased in ethanol treated groups. Testicular activity of GSH-ST was significantly enhanced by ethanol treatment (Table 3 ). In addition ethanol significantly reduced activities of testicular 3β-HSD and 17β-HSD (Table 4) .
Drug exhibited an ability to counteract ethanol induced oxidative challenge as it effectively reduced testicular TBARS and increased tissue, ascorbic acid, GSH (Table 2) , and activities of SOD, catalase, GSH-Red and Se-GSH-Px (Table 3) . Drug had an opposite effect on the activity of GSH-ST. The effect of drug on 3β-HSD and 17β-HSD was not promising (Table 4) .
DISCUSSION
Similar to our previous study chronic ethanol intoxication resulted in body and kidney weight reduction, oxidative stress and inhibited steriodogenic enzymes, 17β and 3β HSD. Treatment with L-ornithine-L-aspartate exhibited an ability to counteract the ethanol induced changes in the testes in preventive and therapeutic models in varying degrees. Reduction in testicular TBARS level in drug treated animals supports its antioxidant role. Raised levels of enzymatic and non enzymatic antioxidants in the drug treated animals elicit protective response.
Explanations against the possible mechanism underlying the protective properties of drugs include the prevention of GSH depletion (18) and destruction of free radicals (19) . Although the controlled generation of reactive oxygen species (ROS) serves as a second messenger system in many different cell types, its continuous production is detrimental to the surrounding tissue (20) . It is reported that excessive ROS production beyond critical levels overwhelm antioxidant defense strategies of spermatozoa in seminal plasma results in increased oxidative stress. ROS are regularly formed during the normal respiration. However, the production is kept at physiologically low levels by intracellular free radical scavengers (21). GSH is a major thiol in living organisms, which plays a central role in coordinating the body's antioxidant defense processes. The tissue GSH concentration reflects its potential for detoxification, preserving the proper cellular redox balance and it's a role as a cellular protectant (22) . GSH-Red is concerned with the maintenance of cellular level of GSH by effecting the fast reduction of oxidized glutathione (GSSG) (23) . GSH-Px plays a major role in peroxyl scavenging mechanism and in maintaining functional integration of the cell membranes, spermatogenesis, sperm morphology and sperm motility (24) . The increased tissue GSH-ST activity on ethanol treatment might be an adaptive mechanism as it plays an essential role in eliminating toxic compounds by conjugation (25) .
However, L-ornithine-L-aspartate supplementation showed a minimal effect on reversing the inhibitory effect of ethanol on steroidogenesis. The antioxidant effect of L-ornithine-Laspartate against oxidative stress induced by ethanol could have contributed some effect on these enzymes. This possibility is supported by the fact that L-ornithine-L-aspartate reversed the extent of lipid peroxidation and restored the testicular scavenger enzymes against free radicals. Low level of testicular free radicals in drug-treated rats was further supported by the recovery of testicular scavenger enzymes against free radicals (26, 27) Gain in the testicular weights in drug-treated rats also supports the low TBRAS and increased activity of steroidogenic enzymes. (28) From the results it may be concluded that L-ornithine-Laspartate has a protective effect on ethanol-induced testicular oxidative stress. The treatment showed only minimal effect in restoring steroidogenesis. 
